Volgen
Rita Ambrus
Rita Ambrus
Geverifieerd e-mailadres voor pharm.u-szeged.hu
Titel
Geciteerd door
Geciteerd door
Jaar
Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam
R Ambrus, P Kocbek, J Kristl, R Šibanc, R Rajkó, P Szabó-Révész
International journal of pharmaceutics 381 (2), 153-159, 2009
1242009
Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation
E Pallagi, R Ambrus, P Szabó-Révész, I Csóka
International journal of pharmaceutics 491 (1-2), 384-392, 2015
1072015
Betulinic Acid in Complex with a Gamma-Cyclodextrin Derivative Decreases Proliferation and in Vivo Tumor Development of Non-Metastatic and Metastatic …
C Soica, C Danciu, G Savoiu-Balint, F Borcan, R Ambrus, I Zupko, F Bojin, ...
International journal of molecular sciences 15 (5), 8235-8255, 2014
1012014
Alginate and hybrid alginate-hyaluronic acid aerogel microspheres as potential carrier for pulmonary drug delivery
T Athamneh, A Amin, E Benke, R Ambrus, CS Leopold, P Gurikov, ...
The journal of supercritical fluids 150, 49-55, 2019
942019
Betulin Complex in γ-Cyclodextrin Derivatives: Properties and Antineoplasic Activities in In Vitro and In Vivo Tumor Models
C Şoica, C Dehelean, C Danciu, HM Wang, G Wenz, R Ambrus, F Bojin, ...
International Journal of Molecular Sciences 13 (11), 14992-15011, 2012
742012
Intranasal nanoparticulate systems as alternative route of drug delivery
A Alshweiat, R Ambrus, II Csóka
Current medicinal chemistry 26 (35), 6459-6492, 2019
702019
Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach
K Karimi, E Pallagi, P Szabó-Révész, I Csóka, R Ambrus
Drug design, development and therapy, 3331-3343, 2016
662016
Formulation and comparison of spray dried non-porous and large porous particles containing meloxicam for pulmonary drug delivery
A Chvatal, R Ambrus, P Party, G Katona, O Jójárt-Laczkovich, ...
International journal of pharmaceutics 559, 68-75, 2019
582019
Improvement of ursolic and oleanolic acids’ antitumor activity by complexation with hydrophilic cyclodextrins
C Oprean, M Mioc, E Csányi, R Ambrus, F Bojin, C Tatu, M Cristea, A Ivan, ...
Biomedicine & Pharmacotherapy 83, 1095-1104, 2016
582016
Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid
K Takács-Novák, V Szőke, G Völgyi, P Horváth, R Ambrus, ...
Journal of pharmaceutical and biomedical analysis 83, 279-285, 2013
582013
Study of the parameters influencing the co-grinding process for the production of meloxicam nanoparticles
L Kürti, Á Kukovecz, G Kozma, R Ambrus, MA Deli, P Szabó-Révész
Powder technology 212 (1), 210-217, 2011
582011
In vitro drug release, permeability, and structural test of ciprofloxacin-loaded nanofibers
LÉ Uhljar, SY Kan, N Radacsi, V Koutsos, P Szabó-Révész, R Ambrus
Pharmaceutics 13 (4), 556, 2021
572021
Applicability of sucrose laurate as surfactant in solid dispersions prepared by melt technology
A Szűts, P Láng, R Ambrus, L Kiss, MA Deli, P Szabó-Révész
International journal of pharmaceutics 410 (1-2), 107-110, 2011
572011
New aspects of developing a dry powder inhalation formulation applying the quality-by-design approach
E Pallagi, K Karimi, R Ambrus, P Szabó-Révész, I Csóka
International journal of pharmaceutics 511 (1), 151-160, 2016
532016
Genistein in 1: 1 inclusion complexes with ramified cyclodextrins: theoretical, physicochemical and biological evaluation
C Danciu, C Soica, M Oltean, S Avram, F Borcan, E Csanyi, R Ambrus, ...
International journal of molecular sciences 15 (2), 1962-1982, 2014
532014
Electrospray crystallization for nanosized pharmaceuticals with improved properties
N Radacsi, R Ambrus, T Szunyogh, P Szabó-Révész, A Stankiewicz, ...
Crystal growth & design 12 (7), 3514-3520, 2012
532012
Analysis of co-spray-dried meloxicam–mannitol systems containing crystalline microcomposites
A Pomázi, R Ambrus, P Sipos, P Szabó-Révész
Journal of pharmaceutical and biomedical analysis 56 (2), 183-190, 2011
532011
Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: preparation, characterization, and in vivo evaluation
A Alshweiat, II Csóka, F Tömösi, T Janáky, A Kovács, R Gáspár, ...
International journal of pharmaceutics 579, 119166, 2020
512020
Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation
A Alshweiat, G Katona, I Csóka, R Ambrus
European Journal of Pharmaceutical Sciences 122, 94-104, 2018
512018
Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach
S Iurian, C Bogdan, I Tomuță, P Szabó-Révész, A Chvatal, SE Leucuța, ...
European Journal of Pharmaceutical Sciences 104, 356-365, 2017
502017
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20